Eli Lilly and Company (LLY) Insider Trading
- $382,403,018.00
- $26,382,711,672.85
- Aug. 12, 2025
- Lilly Endowment Inc
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 12, 2025 | EVP | 1,000 | $634.40 | Buy | $634,400.00 | |
Aug. 12, 2025 | CEO | 1,632 | $644.77 | Buy | $1,052,264.64 | |
Aug. 12, 2025 | Director | 117 | $641.18 | Buy | $75,018.06 | |
Aug. 12, 2025 | Director | 1,565 | $642.33 | Buy | $1,005,246.45 | |
Aug. 8, 2025 | Director | 200 | $639.56 | Buy | $127,912.00 | |
May 5, 2025 | U.S. Congress Member <small>(R-GA)</small> | 0 | $821.66 | Buy | $0.00 | |
March 13, 2025 | CAO | 1,000 | $818.24 | Sell | $818,240.00 | |
Nov. 8, 2024 | CAO | 900 | $803.38 | Sell | $723,042.00 | |
July 10, 2024 | Major Shareholder | 210,000 | $939.82 | Sell | $197,362,200.00 | |
July 8, 2024 | Major Shareholder | 93,593 | $918.64 | Sell | $85,978,273.52 | |
July 5, 2024 | Major Shareholder | 52,369 | $915.18 | Sell | $47,927,061.42 | |
July 3, 2024 | Major Shareholder | 8,848 | $915.31 | Sell | $8,098,662.88 | |
July 1, 2024 | Major Shareholder | 58,749 | $915.26 | Sell | $53,770,609.74 | |
June 28, 2024 | Major Shareholder | 1,441 | $915.02 | Sell | $1,318,543.82 | |
June 24, 2024 | Major Shareholder | 17,229 | $902.38 | Sell | $15,547,105.02 | |
June 20, 2024 | Major Shareholder | 9,671 | $902.67 | Sell | $8,729,721.57 | |
June 17, 2024 | Major Shareholder | 194,978 | $885.91 | Sell | $172,732,959.98 | |
June 14, 2024 | Major Shareholder | 15,022 | $882.47 | Sell | $13,256,464.34 | |
June 10, 2024 | Major Shareholder | 75,510 | $860.78 | Sell | $64,997,497.80 | |
June 7, 2024 | Major Shareholder | 139,490 | $852.29 | Sell | $118,885,932.10 | |
June 5, 2024 | Major Shareholder | 20,383 | $836.32 | Sell | $17,046,710.56 | |
June 3, 2024 | CAO | 750 | $819.47 | Sell | $614,602.50 | |
June 3, 2024 | EVP | 7,056 | $819.38 | Sell | $5,781,545.28 | |
June 3, 2024 | Major Shareholder | 192,794 | $829.77 | Sell | $159,974,677.38 | |
May 31, 2024 | Major Shareholder | 22,206 | $822.11 | Sell | $18,255,774.66 | |
May 28, 2024 | Major Shareholder | 2,052 | $809.00 | Sell | $1,660,068.00 | |
May 24, 2024 | Major Shareholder | 92,563 | $809.21 | Sell | $74,902,905.23 | |
Jan. 31, 2024 | Major Shareholder | 78,573 | $648.07 | Sell | $50,920,804.11 | |
Jan. 29, 2024 | Major Shareholder | 54,032 | $645.07 | Sell | $34,854,422.24 | |
Jan. 16, 2024 | Major Shareholder | 1,180 | $645.60 | Sell | $761,808.00 | |
Jan. 11, 2024 | Major Shareholder | 12,344 | $634.13 | Sell | $7,827,700.72 | |
Jan. 9, 2024 | Major Shareholder | 34,538 | $631.81 | Sell | $21,821,453.78 | |
Jan. 4, 2024 | Major Shareholder | 14,388 | $630.28 | Sell | $9,068,468.64 | |
Nov. 6, 2023 | CAO | 670 | $571.10 | Sell | $382,637.00 | |
Oct. 11, 2023 | Major Shareholder | 215,000 | $605.44 | Sell | $130,169,600.00 | |
Sept. 12, 2023 | EVP | 1,148 | $590.98 | Sell | $678,445.04 | |
Sept. 7, 2023 | Major Shareholder | 210,000 | $571.41 | Sell | $119,996,100.00 | |
Aug. 30, 2023 | Major Shareholder | 6,181 | $555.32 | Sell | $3,432,432.92 | |
Aug. 28, 2023 | Major Shareholder | 37,660 | $546,751.75 | Sell | $20,590,670,905.00 | |
Aug. 25, 2023 | Major Shareholder | 63,572 | $554.38 | Sell | $35,243,045.36 | |
Aug. 23, 2023 | Major Shareholder | 1,307 | $555.69 | Sell | $726,286.83 | |
Aug. 21, 2023 | CAO | 600 | $546.51 | Sell | $327,906.00 | |
Aug. 14, 2023 | Major Shareholder | 164,778 | $539.08 | Sell | $88,828,524.24 | |
Aug. 10, 2023 | Major Shareholder | 3,000 | $528.13 | Sell | $1,584,390.00 | |
Aug. 8, 2023 | Major Shareholder | 204,409 | $523.74 | Sell | $107,057,169.66 | |
July 21, 2023 | Major Shareholder | 591 | $466.62 | Sell | $275,772.42 | |
June 30, 2023 | Major Shareholder | 164,125 | $467.60 | Sell | $76,744,850.00 | |
June 28, 2023 | Major Shareholder | 11,760 | $465.41 | Sell | $5,473,221.60 | |
June 22, 2023 | Major Shareholder | 107,022 | $459.28 | Sell | $49,153,064.16 | |
June 20, 2023 | Major Shareholder | 34,156 | $454.08 | Sell | $15,509,556.48 |
Insiders are both buying and selling Eli Lilly and Company stock.
The insider traders at Eli Lilly and Company are: Lilly Endowment Inc, Donald A Zakrowski, Alfonso G Zulueta, Enrique A Conterno, Jackson P Tai, Susan Mahony, Eli & Co Lilly, Stephen F Fry, Jeffrey N Simmons, Melissa S Barnes, David A Ricks, Joshua L Smiley, Myles O'neill, Anne E White, Alonzo Weems, Derica W Rice, Aarti S Shah, Christi Shaw, Daniel Skovronsky, Fionnuala M Walsh, Jan M Lundberg, Johna Norton, Maria A Crowe, Michael J Harrington, J Erik Fyrwald, R David Hoover, Ilya Yuffa, Gabrielle Sulzberger, LILLY ENDOWMENT INC, David A. Ricks, Marjorie Taylor Greene, Marschall S Runge, Enrique Conterno, Acquisition Corp Kearny, Derica W. Rice, Jacques Tapiero, Jamere Jackson, Patrik Jonsson, and Jackson Tai
The most active insider trader at Eli Lilly and Company is Lilly Endowment Inc with 226 trades.
Lilly Endowment Inc has sold the most Eli Lilly and Company stock with a total value of $26,469,075,393.70.
Acquisition Corp Kearny has bought the most Eli Lilly and Company stock with a total value of $749,816,700.00.
The most recent insider trade for Eli Lilly and Company was on Aug. 12, 2025.
The single biggest insider buy for Eli Lilly and Company was from Acquisition Corp Kearny with a total value of $374,908,350.00 on Nov. 30, 2022.
The single biggest insider sell for Eli Lilly and Company was from Lilly Endowment Inc with a total value of $20,590,670,905.00 on Aug. 28, 2023.